Sla: new treatments of Epo

New studies on the Sla could lead to more positive results. The use of Epo, a banned drug to athletes accused of doping, because it could help the fight against the degeneration of disease



At a Conference which occurred today, the AriSla, fondazione Italiana per la ricerca on Sla, presented to the public eight projects aimed at eradicating the disease. Most important, for now, it seems that alluded to the Epo. LEpo a medicinal product derived from a protein that can protect neurons dallavanzamento of amyotrophic lateral sclerosis. But also a product of which prohibited the use on the part of sports. The discovery is part of the Eposs executed dallIstituto Besta in Milan thanks to funding from the Italian Foundation for research on ALS. The study will aim to test the drug on a group of 50 patients of ALS with the aim to discover the correct dosage of the medicinal product and any toxic. Julius Pompilius, project coordinator for lAriSla, explains that the medicinal product Epo Erythropoietin is derived from a substance capable of increasing the level of red blood cells in the blood and also protect neurons from degeneration natural disease.

Obviously not all testing will be done on men. Dr. Pompilio explains much better study the degenerative process of single neuron of ALS in the laboratory, rather than on men, because that would be very difficult if not impossible. Laboratory scientists create neurons sick approvvigionandoli directly from ALS patients. After studying the behavior of cells, they must also understand if it will be possible to use stem cells obtained from healthy people. In short, a great work, which we hope will lead to good results. Among other studies, in total 8 those tabled today dallAriSla, the one concerning stem cells obtained childlike regenerating lepidermide and study of micro Rna molecules, molecules that govern learning to genes. But also the study that focuses on the genetic heritage of an insect seems to lead to the cure.